Sean Aronow is a motivated medicinal chemist currently serving as a Senior Scientific Lead at Eli Lilly and Company since 2024. They hold a Master of Science in Organic Chemistry from the University of California, Davis, and previously completed a Bachelor's degree in Biotechnology, Chemistry, and Economics from the Rochester Institute of Technology, graduating summa cum laude. Sean's experience includes research on kinase inhibitors for thyroid cancer at Array BioPharma, as well as various roles in the pharmaceutical and academic sectors, where they developed strong skills in organic chemistry and scientific research methodologies. Their long-term aspirations involve becoming a successful engineer, designer, or manager.
This person is not in the org chart
This person is not in any teams
This person is not in any offices